M H13 (Hydralazine 50 mg)
Pill imprint M H13 has been identified as Hydralazine hydrochloride 50 mg.
Hydralazine is used in the treatment of high blood pressure; hypertensive emergency; heart failure and belongs to the drug class vasodilators. Risk cannot be ruled out during pregnancy. Hydralazine 50 mg is not a controlled substance under the Controlled Substance Act (CSA).
Hydralazine hydrochloride
- Imprint:
- M H13
- Strength:
- 50 mg
- Color:
- Pink
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Vasodilators
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-5113
- Inactive Ingredients:
- silicon dioxide
FD&C Red No. 40
FD&C Yellow No. 6
magnesium stearate
microcrystalline cellulose
sodium lauryl sulfate
More about hydralazine
Consumer resources
- Hydralazine
- Hydralazine tablets
- Hydralazine Injection (Advanced Reading)
- Hydralazine Oral, Injection, Intravenous (Advanced Reading)
- Other brands: Apresoline
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
